Suchen
PolyPid Ltd
PYPDZur Watchlist hinzufügen
5.020USD
-0.030-0.59%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
91.38MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über PolyPid Ltd Unternehmen
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
PolyPid Ltd Informationen
BörsenkürzelPYPD
Name des UnternehmensPolyPid Ltd
IPO-datumJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
Anzahl der mitarbeiter57
WertpapierartOrdinary Share
GeschäftsjahresendeJun 26
Addresse18 Hasivim Street, P.O Box 7126
StadtPETAH TIKVA
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl4917002
Telefon972747195700
Websitehttps://www.polypid.com
BörsenkürzelPYPD
IPO-datumJun 26, 2020
CEOAkselbrad (Dikla Czaczkes)
Führungskräfte von PolyPid Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mrs. Anat Tsour Segal
Mrs. Anat Tsour Segal
Independent Director
Independent Director
--
--
Dr. Shaul Mukhtar, Ph.D.
Dr. Shaul Mukhtar, Ph.D.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ms. Dalit Hazan
Ms. Dalit Hazan
Senior Vice President - Research and Development and Regulatory Affairs
Senior Vice President - Research and Development and Regulatory Affairs
--
--
Mr. Nir Dror
Mr. Nir Dror
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Yechezkel Barenholz, Ph.D.
Dr. Yechezkel Barenholz, Ph.D.
Independent Director
Independent Director
2.76K
--
Ms. Dikla Czaczkes Akselbrad
Ms. Dikla Czaczkes Akselbrad
Chief Executive Officer, Director
Chief Executive Officer, Director
934.00
--
Dr. Itzhak Krinsky, Ph.D.
Dr. Itzhak Krinsky, Ph.D.
Independent Director
Independent Director
833.00
--
Mr. Jacob Harel
Mr. Jacob Harel
Independent Chairman of the Board
Independent Chairman of the Board
467.00
--
Mr. Ori Warshavsky
Mr. Ori Warshavsky
Chief Operating Officer - US
Chief Operating Officer - US
267.00
--
Dr. Noam Emanuel, Ph.D.
Dr. Noam Emanuel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von PolyPid Ltd?
Die fünf größten Anteilseigner von PolyPid Ltd sind: Dr. Yechezkel Barenholz, Ph.D.
Wie viele Institutionen halten Anteile an PolyPid Ltd (PYPD)?
Mit Stand vom 2026Q1 halten 33 Institutionen Anteile an PolyPid Ltd, mit einem Gesamtmarktwert von etwa 6.41M, was 33.61% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 15623.00 gestiegen.